Skip to content

Adalimumab

Adalimumab (Humira) is a medicine used for inflammatory conditions, including rheumatoid arthritis, Crohn’s disease and plaque psoriasis. This listing contains Humira in an auto-injector form.

Humira

Rheumatoid Arthritis, Psoriatic Arthritis

20mg / 0.4ml · 40mg / 0.8ml

Adalimumab injectable solution for rheumatoid arthritis and psoriatic arthritis. A biologic that blocks TNF-alpha, a molecule that fuels joint inflammation.

From$285.38/ auto-injectorView

Key points

  • AbbVie is identified as the originator of Humira.
  • The listed strengths are 20mg/0.4ml and 40mg/0.8ml.

What Adalimumab is used for

Adalimumab is listed for Rheumatoid Arthritis and Psoriatic Arthritis, alongside ankylosing spondylitis, Crohn’s disease, ulcerative colitis and plaque psoriasis. The adalimumab listing places Humira in Autoimmune Support.

Further reading